Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

Triple-negative breast cancer (TNBC) remains the poorest-prognosis breast cancer (BC) subtype. Gene expression profiling has identified at least six different triple-negative subtypes with different biology and sensitivity to therapies. The heterogeneous nature of TN tumors may justify the difficult...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Manag Res
Hauptverfasser: Omarini, Claudia, Guaitoli, Giorgia, Pipitone, Stefania, Moscetti, Luca, Cortesi, Laura, Cascinu, Stefano, Piacentini, Federico
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2018
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5772398/
https://ncbi.nlm.nih.gov/pubmed/29391830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S146658
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge